The UK National Screening Committee has advised against routine screening for prostate cancer with the prostate specific antigen (PSA) blood test, saying that the harms would outweigh the benefits.

Patients who receive guideline-concordant treatment for nonmetastatic prostate cancer are more likely to die from other causes. Men with nonmetastatic prostate cancer (PCa) who receive treatment ...

Prostate cancer decision by UK National Screening Committee is expected to reject offering PSA test to Black men and those ...

Michael Ray Richardson’s death at 70 due to prostate cancer highlights the need to pay attention to early symptoms. Know the ...

The Uganda Cancer Institute (UCI) has sounded an urgent warning over a sharp rise in prostate cancer cases, now the most ...

THE NHS “needs to do much better” at diagnosing and treating prostate cancer, Wes Streeting said today. The Health Secretary ...

WASHINGTON -- Former President Joe Biden is battling an "aggressive" form of prostate cancer, his office announced on Sunday, adding his condition is characterized by a "Gleason score of 9." His ...

Prostate cancer screening should not be made routinely available for the vast majority of men in the UK, a committee advising ...

A family history of prostate cancer has long been one of the few universally accepted risk factors for the disease. New findings now provide evidence that risk stratification based on family history ...

John Eimen, a former child star known for his guest spot in "Leave it to Beaver," died from prostate cancer at 76.

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of ...